Evidence map›Paper›PMID 28163933›Full record

ArticleProstate cancer2017

Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes.

Jaroslaw Szczyrba, Volker Jung, Michaela Beitzinger, Elke Nolte, Sven Wach, Martin Hart, Sandra Sapich, Marc Wiesehöfer, Helge Taubert, Gunther Wennemuth and 5 more

Open access · goldAbstract read
In one paragraph

Article in Prostate cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Jaroslaw SzczyrbaInstitute of Virology, Saarland University Medical School, Kirrbergerstrasse, Haus 47, 66421 Homburg/Saar, Germany; Institute of Anatomy, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany.ORCID 0000-0002-5950-0742
Volker JungUniversity Clinic of Urology, Saarland University Medical School, Kirrbergerstrasse, 66421 Homburg/Saar, Germany.
Michaela BeitzingerBiochemistry Center Regensburg (BZR), Laboratory for RNA Biology, 93053 Regensburg, Germany.
Elke NolteUniversity Clinic of Urology, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.
Sven WachUniversity Clinic of Urology, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.
Martin HartInstitute of Virology, Saarland University Medical School, Kirrbergerstrasse, Haus 47, 66421 Homburg/Saar, Germany.
Sandra SapichInstitute of Virology, Saarland University Medical School, Kirrbergerstrasse, Haus 47, 66421 Homburg/Saar, Germany.
Marc WiesehöferInstitute of Anatomy, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany.
Helge TaubertUniversity Clinic of Urology, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.ORCID 0000-0002-9077-1727
Gunther WennemuthInstitute of Anatomy, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany.
Norbert EichnerBiochemistry Center Regensburg (BZR), Laboratory for RNA Biology, 93053 Regensburg, Germany.
Thomas StempflCenter of Excellence for Fluorescent Bioanalytics (KFB), University of Regensburg, 93053 Regensburg, Germany.
Bernd WullichUniversity Clinic of Urology, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.
Gunter MeisterBiochemistry Center Regensburg (BZR), Laboratory for RNA Biology, 93053 Regensburg, Germany.
Friedrich A GrässerInstitute of Virology, Saarland University Medical School, Kirrbergerstrasse, Haus 47, 66421 Homburg/Saar, Germany.ORCID 0000-0001-6234-5571
Friedrich-Alexander-Universität Erlangen-Nürnberg · DESaarland University · DEEssen University Hospital · DEUniversity of Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Posttranscriptional gene regulation by microRNAs (miRNAs) contributes to the induction and maintenance of prostate carcinoma (PCa). To identify mRNAs enriched or removed from Ago2-containing RISC complexes, these complexes were immunoprecipitated from normal prostate fibroblasts (PNFs) and the PCa line DU145 and the bound mRNAs were quantified by microarray. The analysis of Ago complexes derived from PNFs or DU145 confirmed the enrichment or depletion of a variety of mRNAs already known from the literature to be deregulated. Novel potential targets were analyzed by luciferase assays with miRNAs known to be deregulated in PCa. We demonstrate that the mRNAs of the death effector domain-containing protein (DEDD), the tumor necrosis factor receptor superfamily, member 10b protein (TNFRSF10B), the tumor protein p53 inducible nuclear protein 1 (TP53INP1), and the secreted protein, acidic, cysteine-rich (SPARC; osteonectin) are regulated by miRNAs miR-148a, miR-20a, miR-24, and miR-29a/b, respectively. Therefore, these miRNAs represent potential targets for therapy. Surprisingly, overexpression of miR-24 induced focus formation and proliferation of DU145 cells, while miR-29b reduced proliferation. The study confirms genes deregulated in PCa by virtue of their presence/absence in the Ago2-complex. In conjunction with the already published miRNA profiles of PCa, the data can be used to identify miRNA-regulated mRNAs.

Identifiers

PMID28163933
PMCPMC5253174
OpenAlexW2568145770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.